Compounds for the treatment of hepatitis C

US7994171B2 · kind B2 · utility

Assignee

• Bristol-Myers Squibb Company · US

Inventors

• Kap-Sun Yeung · Madison, US
• Kyle E. Parcella · Wallingford, US
• John A. Bender · Middletown, US
• Brett R. Beno · Cromwell, US
• Katharine A. Grant-Young · Madison, US
• Ying Han · Cheshire, US
• Piyasena Hewawasam · Middletown, US
• John F. Kadow · Wallingford, US
• Andrew Nickel · San Marino, US

Key dates

• Filing date: Mar 10, 2010
• Grant date: Aug 9, 2011
• Expiry date: Mar 10, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D491/10
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.